UNAUDITED FINANCIAL RESULT FOR QUARTER ENDED 30.06.2026

CITURGIA BIOCHEMICALS LIMITED Regd. Office: Office No. 427, A-Wing, 4th Floor Floor, Mainframe Premises C.S.L Royal Palms, Aareymilk Colony, Goregaon East, Mumbai-400065 Maharashtra, CIN: L24100MH1974PLC017773 Website: www.citurgiabiochemicals.com; E-mail id: citurgia_bio@yahoo.com Date: 13.08.2026 BSE Limited P J Towers, Dalal Street, Mumbai – 400001 Scrip Code: 506373, Scrip ID: CITURGIA Sub: Submission of Unaudited Financial Results for Quarter ended 30th June, 2026 Dear Sir/Madam, Please find enclosed herewith Unaudited Financial Results for the Quarter ended 30th June, 2026 along with Limited Review Report issued by the statutory auditor for the quarter ended 30th June, 2026 approved by the Board of directors in their meeting held on 12.08.2026. We request you to take the above information on record. Amount In Lakhs Statement of Unaudited Financial Results for the quarter ended 30.06.2026 Quarter Year Ended Particulars 3 Months Preceding 3 Corresponding Current Year Ended Months Ended 3 Months Ended Ended 30.06.2026 31.03.2026 30.06.2025 31.03.2026 (Unaudited) (Unaudited) (Unaudited) (Audited) I. Total Income from Operations - - - - II. Other Income - - - - III. Total Revenue (I+II) - - - - IV. Expenses a) Cost of Materials consumed - - - b) Purchase of Stock-in-trade - - - - c) Changes in inventories of finished goods, WIP - - - - and stock in trade d) Employee benefits expenses 3.00 5.94 3.00 17.74 e) Depreciation and amortization expenses 5.15 5.73 5.15 22.56 f) Other expenses 0.05 14.15 0.24 33.95 Total Expenses 8.20 25.82 8.39 74.25 V Profit/(Loss) before exceptional and (8.20) (25.82) (8.39) (74.25) extraordinary items and tax (III-V) VI Exceptional Items - - - - VII Profit/(Loss) before extraordinary items and tax (8.20) (25.82) (8.39) (74.25) (VI-VII) VIII Extraordinary items - - - - IX Profit/(Loss) before tax (VIII-IX) (8.20) (25.82) (8.39) (74.25) X Tax expenses a) Current Tax - - - - a) Income Tax Adjustment - - - - a) MAT Credit Entitlement - - - - b) Deferred Tax Liabilities / (Assets) - - - - XI Profit (Loss) for the period from continuing (8.20) (25.82) (8.39) (74.25) operations (IX-X) XII Profit/(loss) from discontinuing operations - - - - XIII Tax expense of discontinuing operations - - - - XIV Profit/(loss) from Discontinuing operations (after - - - - tax) (XII-XIII) XV Profit (Loss) for the period (XI + XIV) (8.20) (25.82) (8.39) (74.25) XVI Other Comprehensive Income A (i) Items that will not be reclassified to profit or - - - - loss (ii) Income tax relating to items that will not be - - - - reclassified to profit or loss B (i) Items that will be reclassified to profit or loss - - - - (ii) Income tax relating to items that will be - - - - reclassified to profit or loss XVII Total Comprehensive Income for the period (8.20) (25.82) (8.39) (74.25) (XV+XVI) (Comprising Profit (Loss) and Other Comprehensive Income for the period) XVIII Earnings per equity share (for continuing operation): (1) Basic (0.000) (0.000) (0.000) (0.000) (2) Diluted (0.000) (0.000) (0.000) (0.000) XIX Earnings per equity share (for discontinued operation): (1) Basic - - - - (2) Diluted - - - - XX Earning Per Share (for discontinued & continuing operations) a) Basic (0.000) (0.000) (0.000) (0.000) b) Diluted (0.000) (0.000) (0.000) (0.000) Date : 12.08.2026 Place : Mumbai